[Efficacy of Human Immunodeficiency Virus (HIV) Antigen-Antibody Combination Assay as a Screening Test and Factors Causing False-Positivity].
Takako Inoue(Kaneka (United States)), Yukio Wakimoto, Minoru Oohashi, Noboru Shinkai(Nagoya City University), Tomoyuki Ohike(Nagoya City University Hospital), Takaaki Goto(Nagoya City University Hospital), Shigeru Sato(Japanese Society for Dialysis Therapy), Takayuki Ogiwara(Gunma University), Satomi Kani
PubMed
December 1, 2016
Cited by 0
Related Papers
Gut Dysbiosis Associated With Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|187
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
|Renal Replacement Therapy|2020|170
Hepatitis B virus and its sexually transmitted infection – an update
|Microbial Cell|2016|131
Novel biomarkers for the management of chronic hepatitis B
|Clinical and Molecular Hepatology|2020|128
Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation
|Journal of Hepatology|2021|112